文献速递骨肌乳腺技术与安全MRCTPET

原位大鼠模型中多模态骨转移相关表皮生长因子受体成像

Multimodal Bone Metastasis-associated Epidermal Growth Factor Receptor Imaging in an Orthotopic Rat Model.
PubMed 文献 · Radiol Imaging Cancer · 2021-01-01

研究在大鼠原位三阴性乳腺癌骨转移模型中,采用生物发光成像、SPECT/CT、PET/CT及受体特异性MRI多模态检测EGFR表达。两种肿瘤类型均显示受体特异性初始MRI信号强化较正常骨髓高三至六倍(29.4 vs 4.9;P < .01),micro PET/CT显示EGFR表达异质性并与MRI信号强度区域对应(121.1 vs 93.3;P < .001),影像结果与EGFR蛋白及mRNA高表达相符。

要点

  • 受体特异性MRI可显示骨转移灶EGFR表达,信号强化较正常骨髓高三至六倍。
  • PET/CT显示EGFR表达存在区域异质性,并与MRI信号强度区域对应。
  • 影像所见与EGFR蛋白及mRNA高表达一致。

核心结论

  • 多模态分子受体成像融合可全面评估三阴性乳腺癌转移原位模型中EGFR过表达。

研究设计与样本

  • 研究采用大鼠原位骨转移EGFR阳性三阴性乳腺癌模型,行生物发光成像、SPECT/CT、PET/CT及MRI,并对转录本进行定量分析(n = 22只大鼠);受体特异性MRI通过序贯给予一对抗EGFR抗原结合片段F(ab')2后采集自旋回波T1加权图像,该对片段分别偶联辣根过氧化物酶或葡萄糖氧化酶,并分别使用顺磁性Gd-5HT-DOTAGA底物行MRI、正电子发射68Ga-5HT-DOTAGA底物行PET/CT;EGFR表达经定量逆转录聚合酶链反应和免疫组化分析确认并与影像所见比较。

关键影像表现/征象

  • 经手术动脉内递送三阴性乳腺癌细胞后,大鼠形成快速生长的溶骨性肿瘤或生长缓慢的非溶骨性肿瘤两种类型;两种肿瘤类型均显示受体特异性初始MRI信号强化(对比噪声比)较正常骨髓高三至六倍(29.4 vs 4.9;P < .01);micro PET/CT显示EGFR表达高度异质性,示踪剂区域摄取与感兴趣区MRI信号强度升高相对应(121.1 vs 93.3;P < .001);对转移灶的分析结合影像结果证实,侵袭性肿瘤中EGFR蛋白及信使RNA(mRNA)表达水平高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To develop multimodality imaging techniques for measuring epidermal growth factor receptor (EGFR) as a therapy-relevant and metastasis-associated molecular marker in triple-negative mammary adenocarcinoma metastases. Materials and Methods An orthotopic bone metastasis EGFR-positive, triple-negative breast cancer (TNBC) model in rats was used for bioluminescence imaging, SPECT/CT, PET/CT, and MRI with quantitative analysis of transcripts (n = 22 rats). Receptor-specific MRI of EGFR expression in vivo was performed by acquiring spin-echo T1-weighted images after sequential administration of a pair of anti-EGFR antigen binding fragments, F(ab')2, conjugated to either horseradish peroxidase or glucose oxidase, which have complementing activities, as well as paramagnetic (gadolinium[III]-mono-5-hydroxytryptamide of 2,2',2''-(10-(2,6-dioxotetrahydro-2H-pyran-3-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid, or Gd-5HT-DOTAGA) or positron-emitting (gallium 68-5HT-DOTAGA) substrates for MRI and PET/CT imaging, respectively. EGFR expression was confirmed by quantitative reverse transcriptase polymerase chain reaction and immunohistochemical analyses to compare with image findings. Results After surgical intraarterial delivery of TNBC cells, rats developed tumors that diverged into either rapidly growing osteolytic or slow-growing nonosteolytic tumors. Both tumor types showed receptor-specific initial MRI signal enhancement (contrast-to-noise ratio) that was three to six times higher than that of normal bone marrow (29.4 vs 4.9; P < .01). Micro PET/CT imaging of EGFR expression demonstrated a high level of heterogeneity with regional uptake of the tracer, which corresponded to region-of-interest MRI signal intensity elevation (121.1 vs 93.3; P < .001). Analysis of metastases with corroboration of imaging results showed high levels of EGFR protein and messenger RNA, or mRNA, expression in the invasive tumor. Conclusion Convergence of multimodal molecular receptor imaging enabled comprehensive assessment of EGFR overexpression in an orthotopic model of TNBC metastasis. Keywords: Animal Studies, Molecular Imaging-Cancer, MR-Contrast Agent, Radionuclide Studies, Skeletal-Appendicular, Metastases Supplemental material is available for this article. © RSNA, 2021.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Bäuerle T, Gupta S, Zheng S, et al. Multimodal Bone Metastasis-associated Epidermal Growth Factor Receptor Imaging in an Orthotopic Rat Model. Radiol Imaging Cancer. 2021. PMID: 34170199. doi:10.1148/rycan.2021200069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。